Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
: Study Group 4no-treatment control: 3.9%
Have you tried taking any supplements for your skin
DOSING USED IN PHASE 3 STUDIES In the most recent studies from the TRIUMPH programme (Phase 3) , retatrutide was administered as follows: Route: Subcutaneous Frequency: Once weekly Study duration: Approximately 68 weeks Phase 3 Schedule Recommended Dosage (Clinical Research Escalation Model) Retatrutide is administered once weekly using a gradual dose escalation to improve tolerability
PlexusDx care coordination ensures your medical history is reviewed before starting any medication
US$ 26.26
US$ 28.03
US$ 29.90
US$ 22.87
US$ 21.56
